David S. Goldstein, MD, PHD
NPI 1073638615ActiveIndividual· Specialist, Research Study· Bethesda, MD
Specialist, Research Study (MD, PHD) in Bethesda, Maryland, licensed in MD, with an NPI issued in March 2007. Enrolled in Medicare as order and referring only - general practice. Dendreon Pharmaceuticals LLC was the largest of 3 companies reporting payments in 2025, $289.03 in all, mostly food and beverage.
Overview
| NPI | 1073638615 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD, PHD |
| Sole proprietor | No |
| NPI issued | Mar 20, 2007 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Specialist, Research Study Primary | 1744R1102X | D0023433 | MD |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Enrolled Order and Referring Only - General Practice (MD) |
|---|
Industry payments (Open Payments)
- 2025$289.03 · 12 payments from 3 companies
- 2024$53.77 · 3 payments from 3 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Dendreon Pharmaceuticals LLC | $231.35 | 9 |
| Pfizer Inc. | $36.97 | 2 |
| Bayer Healthcare Pharmaceuticals Inc. | $20.71 | 1 |
What the 2025 payments were for
- Food and Beverage$289.03 · 12 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Specialist, Research Study providers in Bethesda
- 1285113522
- 1104135540
- 1083069710
- 1629394333
- 1255975454
- 1942448758
- 1053542316